| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ChargePoint Holdings, Inc. | Director | Common Stock | 428K | $295K | $0.69 | 08 Jul 2025 | Direct |
| ChargePoint Holdings, Inc. | Director | Common Stock | 421K | $290K | $0.69 | 08 Jul 2025 | By LLC |
| NGM BIOPHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 19.6K | 08 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CHPT | ChargePoint Holdings, Inc. | 08 Jul 2025 | 1 | $0 | 4 | 09 Jul 2025 | Director |
| CHPT | ChargePoint Holdings, Inc. | 09 Jul 2024 | 1 | $0 | 4 | 11 Jul 2024 | Director |
| CHPT | ChargePoint Holdings, Inc. | 18 Jul 2023 | 1 | $0 | 4 | 20 Jul 2023 | Director |
| CHPT | ChargePoint Holdings, Inc. | 12 Jul 2022 | 1 | $0 | 4 | 14 Jul 2022 | Director |
| CHPT | ChargePoint Holdings, Inc. | 12 Jul 2021 | 1 | $0 | 4 | 14 Jul 2021 | Director |
| CHPT | ChargePoint Holdings, Inc. | 01 Jul 2021 | 1 | $0 | 4 | 02 Jul 2021 | Director |
| NGM | NGM BIOPHARMACEUTICALS INC | 08 Jun 2021 | 1 | $0 | 4 | 10 Jun 2021 | Director |
| CHPT | ChargePoint Holdings, Inc. | 27 May 2021 | 1 | $0 | 4 | 01 Jun 2021 | Director |